Skip to Content

RDY 250 (Terbinafine 250 mg)

Pill with imprint RDY 250 is White, Round and has been identified as Terbinafine 250 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Terbinafine is used in the treatment of onychomycosis, toenail; tinea capitis; cutaneous candidiasis; onychomycosis, fingernail; tinea corporis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Terbinafine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for RDY 250


RDY 250
250 mg
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54569-5944 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.